Frontlight ResearchEarly access
Trial site
UCLA Department of Medicine
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Kidney cancer1 trial
- Lung cancer1 trial
- Myelodysplastic syndromes1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 23 trials
- Phase 12 trials
- Phase 1/21 trial
- Status
- Recruiting3 trials
- Terminated2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche1 trial
- Janux Therapeutics1 trial
- Kura Oncology, Inc.1 trial
- Marker Therapeutics, Inc.1 trial
- Orca Biosystems, Inc.1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026